http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103502215-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77138b837856ebf8ab7a5fddced94f23
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
filingDate 2012-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a107516a8d9eb97e629d95167115ff4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64149c5d012c4990182d7a6789daf77e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_269093fafa35951e55e49f152d0e7730
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cabac4375ddaf26decab9ed7860d9dee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56c2741ae231994edc1ced13a25c5648
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1be38d5bb6b79c31835623f4ded303e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49eada14f29c158dea72ee252d029770
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5bcf74d45f33fb7866e1a744591a428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c577c76b7117ede8e0e2ed115d3ca77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_906bce956187f180416b3502f738e542
publicationDate 2014-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103502215-A
titleOfInvention Prodrugs of D-γ-glutamyl-D-tryptophan and D-γ-glutamyl-L-tryptophan
abstract The present invention provides a prodrug of D-γ-glutamyl-[D/L]-tryptophan, said prodrug is a compound of formula I or a pharmaceutically acceptable salt thereof, wherein G is C 1 -C 8 alkyl or benzyl, T is C 1 -C 8 alkyl or benzyl, * is a chiral carbon in (R) or (S) configuration, provided that when * is in (R) configuration, G and At least one of T is a C 5 -C 8 alkyl group; and a use of a compound of formula I in a pharmaceutical composition is provided.
priorityDate 2011-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467318151

Total number of triples: 30.